Table of Contents

Endorsement for INSURE Act, to address crisis in home insurance market
Advocates expressed support for the Incorporating National Support for Unprecedented Risks and Emergencies (INSURE) Act, which would create a federal catastrophic reinsurance program to insulate consumers from unrestrained homeowners insurance cost increases.

Consumer Action supports bill to ban hedge fund ownership of residential housing
Consumer Action is a supporter of the End Hedge Fund Control of American Homes Act of 2023, which would address an urgent issue that has made it more difficult for middle-class Americans to become homeowners and is contribution to America’s twin crises of housing unaffordability and wealth inequality.

CLASS Act would give students defrauded by for-profit colleges their day in court
Advocates supported members of Congress who proposed the Court Legal Access and Student Support (CLASS) Act, legislation that would prohibit a school from receiving federal student aid if it requires mandatory arbitration or otherwise restricts students’ ability to pursue claims against the school in court.

Call for appropriations bills without poison pill policy riders
Democratic lawmakers, supported by a range of organizations, called on Appropriations Committee leadership to advance responsible appropriations legislation free of poison pill provisions and adequately fund non-defense discretionary programs at the caps agreed to in the bipartisan debt ceiling package.

Opposition to amendments that would strip agencies’ powers to protect consumers
In a letter to Senators Murray and Collins, allies strongly opposed any amendments to the Fiscal Year 2024 Military Construction, Veterans Affairs, and Related Agencies Appropriations Act that include provisions that would thwart necessary rulemaking to protect consumers.

Key policies recommended to expand access and lower insulin prices
Consumer Action and dozens of other advocacy organizations joined in a letter urging Majority Leader Schumer to include key policies to expand access and lower insulin prices in the anticipated drug pricing package.

Bipartisan legislation would preserve freedom of payment choice
The Consumer Choice in Payment Coalition, of which Consumer Action is a member, voiced support for legislation that would prohibit retail businesses from refusing cash payment by customers—a practice that denies equal access to unbanked consumers.

More than 50 organizations support the Tax on Wall Street Speculation Act
In a letter to lawmakers, 52 organizations urged active support for the Tax on Wall Street Speculation Act of 2023, sponsored by Sen. Bernie Sanders (I-VT) and Rep. Barbara Lee (D-CA). By enacting a very small tax on the sales of Wall Street trades, the U.S. could begin to address income inequality and ensure Wall Street and the ultra-wealthy pay their fair share of taxes.

Dozens of organizations urge lawmakers to oppose REINS Act
Dozens of advocacy organizations joined in a statement to U.S. Senate members urging them to oppose the Regulations from the Executive in Need of Scrutiny (REINS) Act of 2023, which would halt the implementation of critical new protections.

Groups urge U.S. senators to advance legislation that would result in lower drug prices
More than 40 advocacy organizations sent a letter to the 118th Senate urging the lawmakers to advance legislation would result in lower drug prices for millions.